Key result
Pre-stenting with a bare metal stent before PPVI was associated with a reduced risk of developing PPVI stent fractures compared to PPVI alone (HR 0.35; 95% CI 0.14-0.87; p=0.024).
Why the study?
Does pre-stenting with a bare metal stent before PPVI reduce stent fractures and improve outcomes in patients with congenital heart disease?
Population
108 consecutive patients with congenital heart disease undergoing percutaneous pulmonary valve implantation
Comparison
Pre-stenting with a bare metal stent before… vs Percutaneous pulmonary valve implantation alone
Design
Cohort
Follow-up
1 year
Authors
Loading...
May support pre-stenting before PPVI to lower fracture risk; leaves open confirmation in randomized trials.
Cohort (n=108)
No
Does pre-stenting with a bare metal stent before PPVI reduce stent fractures and improve outcomes in patients with congenital heart disease?
Hazard Ratio: 0.35 (95% CI 0.14–0.87)
Absolute Event Rate: 18% vs 31%
p-value: p=0.024
Pre-stenting with a bare metal stent before percutaneous pulmonary valve implantation is safe and significantly reduces the risk of subsequent stent fractures.
Nordmeyer et al. (2010) conducted a cohort in Congenital heart disease requiring percutaneous pulmonary valve implantation (n=108). Pre-stenting with a bare metal stent (BMS) vs. Percutaneous pulmonary valve implantation (PPVI) alone was evaluated on PPVI stent fractures (HR 0.35, 95% CI 0.14 to 0.87, p=0.024). Pre-stenting with a bare metal stent before PPVI was associated with a reduced risk of developing PPVI stent fractures compared to PPVI alone (HR 0.35; 95% CI 0.14-0.87; p=0.024).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: